Skip to main content
# Title Research Year
141 Serum profiles of extracellular matrix degradation inhibitors across the stages of liver fibrosis in chronic hepatitis C patients. Assiut Med.J 2014
142 Impact of Liver Biopsy on the Decision to Treat Patients with Chronic Hepatitis B Genotype D Virus Infection. 2014
143 To treat or not to treat the" immunotolerant phase" of hepatitis B infection: A tunnel of controversy 2014
144 Serum profiles of extracellular matrix degradation inhibitors arcross the stages of liver fibrosis in chronic hepatitis C patients 2014
145 IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection 2013
146 Risk factors for progression of chronic hepatitis C infection to cirrhosis in rural Upper Egypt: A retrospective study 2013
147 Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients 2013
148 Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia 2013
149 Risk factors for progression of chronic hepatitis C infection to cirrhosis in rural Upper Egypt: A retrospective study 2013
150 A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience 2013